Latest in 'We're in it to win it' Boulter & Raducanu put GB into BJK Cup semis
Sort by
3,065 items
-
We're buying more shares on the dip in this Fed rate-cut stock tied to housing
Some of this decline is probably due to profit-taking since the stock has gone straight up since Sept. 6.Business - CNBC - October 22 -
We're trimming a bank stock on tear since earnings, booking nearly a 100% profit
This sale does not reflect any change in our long-standing positive view on the bank and the job the CEO is doing.Business - CNBC - October 25 -
Colts coach Shane Steichen won't commit to QB Anthony Richardson starting next week: 'We're evaluating'
Richardson was thrown into the fire as an NFL starter from Day 1 despite being a raw prospect. Would he and the Colts benefit from a QB change that allows him to develop from the bench?Sports - Yahoo Sports - October 28 -
Colts' Shane Steichen says 'we're evaluating everything' when asked if Anthony Richardson will start Week 9
The Colts are 4-4 and coming off a divisional lossSports - CBS Sports - October 28 -
We're making a flurry of trades: Buying 2 beaten-up stocks, taking profits in another
We're using proceeds from the sale to help fund our purchases of two other Club stocks.Business - CNBC - October 29 -
Alphabet's two pillars of growth stand tall in the latest quarter. But we're not ready to act
Alphabet shares surged during Tuesday's after-hours trading following a solid earnings print.Business - CNBC - October 30 -
We may think we're done with COVID-19, but COVID-19 is not done with us
As we approach a new presidential administration and a new Congress, we cannot regard COVID-19 as one of several respiratory diseases that can be dealt with through a vaccination program and other ...Politics - The Hill - October 30 -
We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts
While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher.Business - CNBC - October 30 -
Meta's stock drop tells the wrong story on earnings — so, we're boosting our price target
Don't let the after-hours stock action fool you, Meta delivered one heck of a strong quarter and rosy revenue guidance.Business - CNBC - October 31 -
Start of a Dodgers dynasty? MLB's exemplary franchise primed for more titles: 'I think that we're on our way'
The Dodgers won the World Series in Year 1 of Shohei Ohtani's 10-year contractSports - CBS Sports - October 31 -
We're buying this stock for the second time this week, taking advantage post-earnings selling
The roughly 10% decline in shares since earnings is too excessive.Business - CNBC - October 31 -
We're hiking our price target on an industrial whose earnings benefit from AI data center boom
Given Eaton stock's year-to-date outperformance, it's not too surprising to see some profit taking on the mixed print.Business - CNBC - October 31 -
We're buying more of two stocks that have been unfairly dinged in the past week
We can finally add to our positions now that our trading restrictions are cleared.Business - CNBC - November 4 -
Financial stocks are leading Wednesday's market rally. We're buying the one left behind
We're using some of the sale proceeds from our morning bank stock trims.Business - CNBC - November 6 -
With non-football early signing period upon us, we're about to see how messy college sports is going to get
In a way, college athletics enters the next phase of its evolution into a more professionalized entity this week as the early signing period opens up.Sports - Yahoo Sports - 4 days ago -
Navarro: 'We're not going to have a Trump Cabinet' with Thune or Cornyn leading Senate GOP
Former White House aide Peter Navarro questioned whether President-elect Trump’s nominees could get confirmed if either Sen. John Thune (R-S.D.) or Sen. John Cornyn (R -Texas) is elected as Senate ...Politics - The Hill - 4 days ago -
We're overhauling our Bullpen watchlist — 3 stocks are gone, the rest stick around
Jim Cramer ran through the 10 stocks in the CNBC Investing Club's Bullpen during the November Monthly Meeting.Business - CNBC - 2 days ago -
How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.Business - CNBC - 2 days ago